A growing body of evidence has demonstrated that specific alterations in the activity of the translation machinery driven by oncogenic signaling pathways direct tumor initiation and progression in prostate cancer through the aberrant translation of distinct mRNA networks, which include YB-1 and MTA1 [5]. This evidence concerns the gene YBX1 and prostate carcinoma.